Because VEGF-C might be a major factor responsible for post-irradiation disease progression in HNSCC patients, via promotion of lymphangiogenesis, we further started investigating the mechanisms involved in its induction, which may serve to its therapeutic targeting. This evidence concerns the gene VEGFC and head and neck squamous cell carcinoma.